(As the above-mentioned article had already been printed, the additional material here could not appear as a "Note added in proof.") Neuromedin K (= neurokinin B) has been found to possess weak biological activity compared to other members of the tachykinin family in spite of marked structural similarities (Hua et al. 1984; Vaught et al. 1984) . However, this may be due to solubility problems, since the manufacturer of neuromedin K has now supplied instructions how to dissolve this peptide in a proper way. Thus, after dissolving neuromedin K in 500% trifluoroacetic acid (TFA), neutralizing the solution with NaOH and diluting the peptide in Krebs solution, the following functional effects were obtained upon i.v. injection of 2.5 nmol x kg-1 in anaesthetized guinea-pigs: arterial blood-pressure decrease 42 + 5 mm Hg (n = 4), no significant heart-rate change, insuffiation-pressure increase 3.9 _+ 0.4 kPa (n = 4), Evans blue content compared to control of the ureter 59 _+ 8 vs. 7 _+ 1, trachea: 44 +_ 9 vs. 10 + 2, esophagus 28 _+ 2 vs. 9 + 1 and skin of paw 20 _+ 5 vs. 8 _+ 1 ng/mg (n = 4 of each). Thus, at this dose neuromedin K displays stronger insufflation-pressure activity than substance P (SP), but a somewhat weaker protein-extravasation response (Hua et al. 1984) . A poor solubility of neuromedin K in 0.01 M acetic acid may also possibly account for the weak biological activity in the hindlimb scratching model by Vaught et al. 1984 .
